The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity
Summary Background The Food and Drug Administration has approved several pharmacotherapies for the treatment of obesity. This study assesses the cost‐effectiveness of six pharmacotherapies and lifestyle intervention for people with mild obesity (body mass indices [BMIs] 30 to 35). Methods A microsim...
Saved in:
Main Authors: | Minyi Lee (Author), Brianna N. Lauren (Author), Tiannan Zhan (Author), Jin Choi (Author), Matthew Klebanoff (Author), Barham Abu Dayyeh (Author), Elsie M. Taveras (Author), Kathleen Corey (Author), Lee Kaplan (Author), Chin Hur (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between unmet social needs and healthy lifestyle parenting behaviors
by: Kelsey A. Egan, et al.
Published: (2023) -
Recent Clinical Results of Endoscopic Bariatric Therapies as an Obesity Intervention
by: Fateh Bazerbachi, et al.
Published: (2017) -
Cost analysis of epilepsy pharmacotherapy by valproic acid and carbamazepine
by: Ia. O. Grynkiv, et al.
Published: (2018) -
Application of the cost-effectiveness method in improving the pharmacotherapy of multiple myeloma
by: E. A. Luchinin, et al.
Published: (2023) -
Analysis of the cost-effectiveness of early diagnosis and pharmacotherapy of pulmonary arterial hypertension
by: I. S. Datsenko
Published: (2023)